¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå : Medtech 360
Interventional Oncology Devices | Medtech 360 | Market Insights | Asia Pacific
»óǰÄÚµå : 1510796
¸®¼­Ä¡»ç : Clarivate
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 10,388 £Ü 14,741,000
Web Access and PDF Download (Corporate Use License) help
µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½º ÀÔ´Ï´Ù. À̸ÞÀÏ·Î ¸µÅ©¿Í ºñ¹Ð¹øÈ£¸¦ º¸³» µå¸³´Ï´Ù. ÀÎÅÍ³Ý ¿¬°á·Î ¿­¶÷ÀÌ °¡´ÉÇϰí PDF º¸°í¼­ ´Ù¿î·Îµå°¡ °¡´ÉÇÕ´Ï´Ù. ÀμⰡ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â PDF ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀåÀº ȯÀÚ ¼ö°¡ ±ÞÁõÇϰí ÀÖ°í, ÃÖ¼Òħ½À ¼ö¼úÀÇ ÀαⰡ ³ô¾ÆÁö°í, ÀÓ»ó °¡À̵å¶óÀÎÀÌ °³¼±µÇ°í, Ä¡·á Á¢±Ù¼ºÀÌ Çâ»óµÇ°í, ÁßÀçÀû Á¾¾çÇÐ ½Ã¼ú¿¡ ´ëÇÑ ÀÇ»çµéÀÇ ¼ö¿ëµµ°¡ ³ô¾ÆÁü¿¡ µû¶ó 2033³â±îÁö 2033³â±îÁö °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¸, ÀÌ Áö¿ª¿¡¼­´Â º¸Çè ȯ±ÞÀÇ ºÎÁ·°ú Áö¼ÓÀûÀÎ ºñ¿ë Á¦¾àÀ¸·Î ÀÎÇØ °í°¡ ÀåºñÀÇ µµÀÔÀÌ Á¦Çѵǰí ÀÖ´Ù´Â Á¡ÀÌ ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÌ º¸°í¼­´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ µ¥ÀÌÅÍ¿Í ºÐ¼®(2019-2033³â)À» Á¦°øÇÕ´Ï´Ù.

¹Ì°³Ã´ÁöÀÎ Àεµ¿Í Áß±¹ÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀåÀº °­·ÂÇÑ ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

ºñ¿ë¿¡ ¹Î°¨ÇÑ ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½Ã¼úÀÇ Ã¤Åÿ¡ ÀÖ¾î ºñ¿ë »óȯÀº ¸Å¿ì Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù.

±àÁ¤ÀûÀÎ ÀÓ»ó µ¥ÀÌÅÍ´Â ÁßÀçÀû Á¾¾çÇÐ ±â±â, ƯÈ÷ ¹æ»ç¼º »öÀü¼ú ¹× DEB¿Í °°Àº °í°¡ ÀåºñÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀÔ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå¿¡¼­ ±¹³» Á¦Á¶¾÷üÀÇ ¿µÇâ·Â Áõ°¡´Â ÇâÈÄ ½ÃÀå Æ®·»µå¸¦ º¯È­½Ãų °ÍÀÔ´Ï´Ù.

ÀýÁ¦¿ä¹ýÀº °£¾Ï, ½ÅÀå¾Ï, Æó¾ÏÀÇ ÀûÀÀÁõÀ¸·Î ÇâÈÄ¿¡µµ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È ÀýÁ¦¿ä¹ýº° µµÀÔ Ãß¼¼°¡ º¯È­ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

¾Æ½Ã¾ÆÅÂÆò¾ç

°³¿ä

ÁÖ¿ä ¿ä¾à

ÁÖ¿ä º¸°í¼­ ¾÷µ¥ÀÌÆ® ÀÌ·Â

ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå

ÀýÁ¦ ±â±â ½ÃÀå

»öÀü ±â±â ½ÃÀå

¾×¼¼¼­¸® µð¹ÙÀ̽º ½ÃÀå

ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Asia Pacific interventional oncology device market will see strong growth through 2033, driven by large and rapidly expanding patient population, increasing popularity of minimally invasive surgeries, favorable clinical guidelines, improving access to treatment, and growing physician acceptance of interventional oncology procedures. However, a lack of reimbursement and ongoing cost constraints in the region limiting the adoption of premium-priced devices will remain a challenge for this market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the Asia Pacific region from 2019 to 2033.

The underpenetrated Indian and Chinese interventional oncology device markets have strong growth potential.

Reimbursement will be a crucial factor in the adoption of interventional oncology procedures in the cost-conscious Asia Pacific region.

Positive clinical data will play a key role in driving the adoption of interventional oncology devices, especially the premium-priced devices such as radioembolization spheres and DEBs.

Increasing influence of domestic manufacturers in the Asia Pacific interventional oncology device market will change market dynamics in the future.

Ablation therapy procedures will continue to grow for the liver, kidney, and lung cancer indications and will witness change in adoption trends for different ablation modalities over the forecast period.

Table of Contents

Asia Pacific

Abstract

Executive Summary

Key Report Updates

Interventional Oncology Device Market

Ablation Device Market

Embolization Device Market

Accessory Device Market

Appendix

Tables and Figures

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â